Vercide, Danica Joy .

HRN: 27-87-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFUROXIME 500MG (TAB)
09/28/2025
10/05/2025
PO
500 Mg
BID
S/P NSVD, Postpartum Hemorrhage (referral)
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: